BioTime Inc (NYSE American:BTX)

2.37
Delayed Data
As of Jul 20
 +0.01 / +0.42%
Today’s Change
1.98
Today|||52-Week Range
3.16
+10.23%
Year-to-Date
BioTime (BTX) in Focus: Stock Moves 7.3% Higher
Jul 12 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.36
Today’s open2.37
Day’s range2.31 - 2.41
Volume603,427
Average volume (3 months)414,402
Market cap$300.7M
Data as of 8:00pm ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)-150.00%
Earnings growth (this year)-247.06%
Earnings growth (next 5 years)--
Revenue growth (last year)-41.62%
P/E ratioNM
Price/Sales71.18
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp-0.05-1.44%
EDGEEdge Therapeutics In...-0.02-1.96%
AGENAgenus Inc-0.12-5.36%
BLCMBellicum Pharmaceuti...-0.17-2.24%
Data as of 4:15pm ET, 07/20/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$3.5M
Annual profit (last year)-$20.0M
Net profit margin-577.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Co-Chief Executive Officer &
Director
Michael D. West
President, Co-Chief Executive Officer &
Director
Adi Mohanty
Corporate headquarters
Alameda, California

Forecasts